Literature DB >> 26862932

Ratio of platelet count/spleen diameter predicted the presence of esophageal varices in patients with schistosomiasis liver cirrhosis.

Xiao-Dan Xu1, Chun-Fang Xu, Jian-Jun Dai, Jian-Qing Qian, Xun Pin.   

Abstract

AIM: To examine the platelet count (PC)/spleen diameter (SD) ratio in predicting the presence of esophageal varices (EV) in patients with schistosomiasis liver cirrhosis.
MATERIALS AND METHODS: A total of 95 consecutive patients with EV induced by schistosomiasis liver cirrhosis were enrolled in this trial. A total of 141 schistosomiasis liver cirrhosis patients without EV were enrolled as controls. All patients were diagnosed by endoscopy. Demographic, laboratory, and Doppler ultrasound parameters were collected and analyzed. Binary logistic regression analysis was carried out to identify independent risk factors associated with EV occurrence. Receiver operating curves were generated to obtain the PC/SD ratio cutoff values for the optimal sensitivity and specificity with respect to EV.
RESULTS: The accuracy was increased in diagnosing for EV using the ratio of PC/SD compared with the SD alone [area under the curve: 0.891 95% confidence interval (CI): 0.844-0.928 vs. 0.764 95% CI: 0.705-0.817; P<0.01]. The optimal cutoff value was 1004, with a 77.1% (95% CI: 67.9-84.8%) positive-predictive value and an 89.3% (95% CI: 82.7-94.0%) negative-predictive value. Using a cutoff of 1004, it was determined that 117/141 (83.0%) patients without EV could avoid undergoing unnecessary endoscopy, whereas 14/95 (14.7%) patients with EV would be misdiagnosed. In contrast, when the ratio was set at 909, the positive-predictive and negative-predictive values were 79.5% (95% CI: 69.5-87.4%) and 83.1% (95% CI: 76.1-88.8%), respectively. A ratio of 909 would accurately predict the absence of EV in 123/141 (87.2%) patients; however, 24/95 (25.3%) patients with EV would miss the necessary screening endoscopy.
CONCLUSION: The ratio of PC/SD was a useful marker in predicting the presence of EV in patients with schistosomiasis liver cirrhosis.

Entities:  

Mesh:

Year:  2016        PMID: 26862932     DOI: 10.1097/MEG.0000000000000584

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  10 in total

Review 1.  Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.

Authors:  Agostino Colli; Juan Cristóbal Gana; Jason Yap; Thomasin Adams-Webber; Natalie Rashkovan; Simon C Ling; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2017-04-26

Review 2.  Noninvasive diagnosis of periportal fibrosis in schistosomiasis mansoni: A comprehensive review.

Authors:  Joelma Carvalho Santos; Caroline Louise Diniz Pereira; Ana Lúcia Coutinho Domingues; Edmundo Pessoa Lopes
Journal:  World J Hepatol       Date:  2022-04-27

3.  [Splenic thickness combined with routine clinical markers predicts esophageal varices in patients with liver cirrhosis].

Authors:  Ge-Yang Dai; Zhi Liu; Fan Zeng; Dan Zhou; Lin Dai
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-10-20

4.  Schistosoma mansoni-related periportal fibrosis; can we use APRI and PSDR levels in the real-time selection of patients for targeted endoscopy in a resource-limited setting? A case-control study.

Authors:  Daniel W Gunda; Elizabeth F Mtui; Paulina M Manyiri; David C Majinge; Semvua B Kilonzo; Humphrey D Mazigo; Benson R Kidenya
Journal:  BMC Gastroenterol       Date:  2021-05-13       Impact factor: 3.067

Review 5.  Diagnosis and clinical management of hepatosplenic schistosomiasis: A scoping review of the literature.

Authors:  Francesca Tamarozzi; Veronica A Fittipaldo; Hans Martin Orth; Joachim Richter; Dora Buonfrate; Niccolò Riccardi; Federico G Gobbi
Journal:  PLoS Negl Trop Dis       Date:  2021-03-25

Review 6.  Platelet Count to Spleen Diameter Ratio for the Diagnosis of Gastroesophageal Varices in Liver Cirrhosis: A Systematic Review and Meta-Analysis.

Authors:  Runhua Chen; Han Deng; Xia Ding; Chune Xie; Wei Wang; Qian Shen
Journal:  Gastroenterol Res Pract       Date:  2017-02-08       Impact factor: 2.260

Review 7.  Morbidity and Mortality Due to Schistosoma mansoni Related Periportal Fibrosis: Could Early Diagnosis of Varices Improve the Outcome Following Available Treatment Modalities in Sub Saharan Africa? A Scoping Review.

Authors:  Daniel W Gunda; Semvua B Kilonzo; Paulina M Manyiri; Robert N Peck; Humphrey D Mazigo
Journal:  Trop Med Infect Dis       Date:  2020-02-03

8.  The diagnostic accuracy of routine clinical findings for detection of esophageal varices in rural sub-Saharan Africa where schistosomiasis is endemic.

Authors:  Christopher K Opio; Lalitha Rejani; Francis Kazibwe; Ponsiano Ocama
Journal:  Afr Health Sci       Date:  2019-12       Impact factor: 0.927

9.  Non-Invasive Prediction Models for Esophageal Varices and Red Signs in Patients With Hepatitis B Virus-Related Liver Cirrhosis.

Authors:  Huixin Liang; Hang Si; Mingzhu Liu; Lianxiong Yuan; Ruiying Ma; Genglin Zhang; Jianrong Yang; Zhishuo Mo; Qiyi Zhao
Journal:  Front Mol Biosci       Date:  2022-07-12

Review 10.  Νon-invasive screening for esophageal varices in patients with liver cirrhosis.

Authors:  Andreas Karatzas; Christos Konstantakis; Ioanna Aggeletopoulou; Christina Kalogeropoulou; Konstantinos Thomopoulos; Christos Triantos
Journal:  Ann Gastroenterol       Date:  2018-03-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.